TelyRx Holdings Inc. (TSX:TELY)
2.410
-0.040 (-1.63%)
At close: Jun 24, 2026
TelyRx Holdings Revenue
TelyRx Holdings had revenue of $19.39M USD in the quarter ending March 31, 2026, with 313.96% growth. This brings the company's revenue in the last twelve months to $55.39M. In the year 2025, TelyRx Holdings had annual revenue of $42.92M with 350.27% growth.
Revenue (ttm)
$55.39M
Revenue Growth
+350.27%
P/S Ratio
1.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
117.73M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.92M | 33.39M | 350.27% |
| Dec 31, 2024 | 9.53M | 9.51M | 35,207.41% |
| Dec 31, 2023 | 27.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTelyRx Holdings News
- 9 days ago - TelyRx Announces Voting Results from Annual General Meeting of Shareholders - Newsfile Corp
- 16 days ago - TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy - Newsfile Corp
- 19 days ago - TelyRx Commences Trading on the OTCQX Market in the United States - Newsfile Corp
- 20 days ago - TelyRx Holdings Transcript: Small Cap Growth Virtual Investor Conference - Transcripts
- 6 weeks ago - TelyRx Holdings Transcript: Transcript - Transcripts
- 6 weeks ago - TelyRx Holdings Slides: Investor presentation - Filings